Breaking News Instant updates and real-time market news.

HTBX

Heat Biologics

$2.87

-0.11 (-3.69%)

17:32
11/30/16
11/30
17:32
11/30/16
17:32

Heat Biologics' HS-410 bladder cancer trial did not meet primary endpoint

Heat Biologics presented topline data from its 94-patient Phase II trial evaluating HS-410 in combination with standard of care, Bacillus Calmette-Guerin, or as a monotherapy, for the treatment of non-muscle invasive bladder cancer, at the Society of Urologic Oncology Annual Meeting in San Antonio, TX. Researchers reported that there were encouraging signs of anti-tumor activity as HS-410 generated a robust antigen-specific immune response to multiple tumor-associated peptides in treated patients, while there were no immune responses of this type in the placebo. However, these responses did not translate into clinical outcomes, and there was no statistically significant difference in the primary endpoint - proportion of recurrence-free survival at one year - between the vaccine and placebo arms of the trial. Heat will continue to monitor all patients enrolled in the study for an additional 12 months. At that time, Heat will make a final determination whether to progress its bladder cancer program into a Phase 3 trial.

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

HTBX Heat Biologics
$2.87

-0.11 (-3.69%)

01/08/16
NBLE
01/08/16
INITIATION
Target $16
NBLE
Buy
Heat Biologics initiated with a Buy at Noble Financial
Noble Financial analyst Rahul Jasuja initiated Heat Biologics with a Buy rating and $16 price target on shares.
02/04/16
CANT
02/04/16
DOWNGRADE
CANT
Speculative Buy
Heat Biologics downgraded to Speculative Buy from Buy at Cantor
Cantor Fitzgerald downgraded Heat Biologics to Speculative Buy saying the partial clinical hold for HS-410 adds uncertainty. The analyst has a fair value range for shares of $2-$12.
02/04/16
02/04/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Anglo Platinum (AGPPY) downgraded to Neutral from Overweight at JPMorgan... Buffalo Wild Wings (BWLD) downgraded to Neutral from Buy at Longbow... Changyou.com (CYOU) downgraded to Neutral from Outperform at Credit Suisse... Enbridge (ENB) downgraded to Neutral from Outperform at Credit Suisse... Esterline (ESL) downgraded to Hold at Drexel Hamilton... Franco-Nevada (FNV) downgraded to Neutral from Outperform at Credit Suisse... GoPro (GPRO) downgraded on results, guidance at Sterne Agee CRT... Heat Biologics (HTBX) downgraded to Speculative Buy from Buy at Cantor... Illumina (ILMN) downgraded to Hold from Buy at Canaccord... Intrawest Resorts (SNOW) downgraded to Neutral from Outperform at Macquarie... Match Group (MTCH) downgraded to Equal Weight from Overweight at Barclays... Memorial Resource (MRD) downgraded to Hold from Accumulate at Tudor Pickering... Pacific Biosciences (PACB) downgraded to Neutral from Overweight at Piper Jaffray... Peabody (BTU) downgraded to Underperform from Market Perform at FBR Capital... Peak Resorts (SKIS) downgraded to Underperform from Neutral at Macquarie... PennyMac Mortgage (PMT) downgraded to Market Perform from Outperform at Wells Fargo... Petrobras (PBR) downgraded to Underweight from Neutral at JPMorgan... Sensata (ST) downgraded to Neutral from Overweight at Atlantic Equities... Shutterfly (SFLY) downgraded to Neutral from Buy at BofA/Merrill... Star Bulk Carriers (SBLK) downgraded to Neutral from Speculative Buy at Seaport Global... Synchronoss (SNCR) downgraded at Stifel... Wabtec (WAB) downgraded to Neutral from Buy at Goldman.
06/20/16
ROTH
06/20/16
INITIATION
Target $2.75
ROTH
Buy
Heat Biologics initiated with a Buy at Roth Capital
Roth Capital analyst Joseph Pantginis started Heat Biologics with a Buy rating and $2.75 price target. Heat owns a "portfolio of unique, differentiated vaccines," Pantginis tells investors in a research note.

TODAY'S FREE FLY STORIES

DIA

Diamonds Fund ETF

$260.16

-0.92 (-0.35%)

08:18
01/19/18
01/19
08:18
01/19/18
08:18
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPN

Dolphin Entertainment

$3.15

-0.1 (-3.08%)

08:17
01/19/18
01/19
08:17
01/19/18
08:17
Initiation
Dolphin Entertainment initiated  »

Dolphin Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$279.14

-0.47 (-0.17%)

08:17
01/19/18
01/19
08:17
01/19/18
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$29.33

-0.04 (-0.14%)

08:17
01/19/18
01/19
08:17
01/19/18
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$106.67

0.78 (0.74%)

08:17
01/19/18
01/19
08:17
01/19/18
08:17
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

PowerShares QQQ Trust

$165.82

0.03 (0.02%)

08:16
01/19/18
01/19
08:16
01/19/18
08:16
Technical Analysis
PowerShares QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

08:16
01/19/18
01/19
08:16
01/19/18
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$6,811.38

1.09471 (0.02%)

08:16
01/19/18
01/19
08:16
01/19/18
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:15
01/19/18
01/19
08:15
01/19/18
08:15
General news
Boston Fed dove Bostic will be taking part in an "informal discussion" »

Boston Fed dove Bostic…

SYF

Synchrony

$37.30

-0.76 (-2.00%)

, PYPL

PayPal

$82.94

0.47 (0.57%)

08:14
01/19/18
01/19
08:14
01/19/18
08:14
Hot Stocks
Synchrony comments on 2018 outlook in presentation slides »

Synchrony's (SYF)…

SYF

Synchrony

$37.30

-0.76 (-2.00%)

PYPL

PayPal

$82.94

0.47 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 08

    Mar

MLNX

Mellanox

$65.10

0.8 (1.24%)

, INTC

Intel

$44.48

0.09 (0.20%)

08:14
01/19/18
01/19
08:14
01/19/18
08:14
Recommendations
Mellanox, Intel, AMD analyst commentary  »

Mellanox price target…

MLNX

Mellanox

$65.10

0.8 (1.24%)

INTC

Intel

$44.48

0.09 (0.20%)

AMD

AMD

$12.47

0.29 (2.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 30

    Jan

SIRI

SiriusXM

$5.47

0.03 (0.55%)

08:13
01/19/18
01/19
08:13
01/19/18
08:13
Initiation
SiriusXM initiated  »

SiriusXM initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

WNS

WNS Holdings

$45.28

2.31 (5.38%)

08:12
01/19/18
01/19
08:12
01/19/18
08:12
Recommendations
WNS Holdings analyst commentary  »

WNS Holdings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$12.13

0.01 (0.08%)

08:12
01/19/18
01/19
08:12
01/19/18
08:12
Periodicals
Petrobras owes Brazil billions but unlikely to pay in 2018, Reuters reports »

Brazilian state-owned oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAMP

CalAmp

$22.90

-0.04 (-0.17%)

08:12
01/19/18
01/19
08:12
01/19/18
08:12
Conference/Events
CalAmp has a conference call hosted by JPMorgan »

JPMorgan Analyst Coster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

FL

Foot Locker

$48.59

0.83 (1.74%)

08:12
01/19/18
01/19
08:12
01/19/18
08:12
Upgrade
Foot Locker rating change  »

Foot Locker upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$76.37

-0.84 (-1.09%)

08:11
01/19/18
01/19
08:11
01/19/18
08:11
Hot Stocks
Schlumberger sees FY18 effective tax rate similar to 4Q17 »

Management said, "As…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

08:10
01/19/18
01/19
08:10
01/19/18
08:10
General news
Canada manufacturing preview »

Canada manufacturing…

VRNS

Varonis

$52.80

-0.1 (-0.19%)

08:08
01/19/18
01/19
08:08
01/19/18
08:08
Recommendations
Varonis analyst commentary  »

Varonis price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

  • 26

    Feb

SLB

Schlumberger

$76.37

-0.84 (-1.09%)

08:08
01/19/18
01/19
08:08
01/19/18
08:08
Hot Stocks
Schlumberger CEO: Oil market to continue to see strong growth in demand in 2018 »

Earlier, Schlumberger CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

FB

Facebook

$179.80

2.2 (1.24%)

08:08
01/19/18
01/19
08:08
01/19/18
08:08
Hot Stocks
WhatsApp introduces WhatsApp Business app »

WhatsApp says in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 28

    Feb

AVT

Avnet

$41.32

-0.33 (-0.79%)

, ARW

Arrow Electronics

$84.13

0.3 (0.36%)

08:08
01/19/18
01/19
08:08
01/19/18
08:08
Upgrade
Avnet, Arrow Electronics, ON Semiconductor, TE Connectivity rating change  »

Avnet upgraded to Buy…

AVT

Avnet

$41.32

-0.33 (-0.79%)

ARW

Arrow Electronics

$84.13

0.3 (0.36%)

ON

ON Semiconductor

$24.74

0.82 (3.43%)

TEL

TE Connectivity

$99.97

-0.6 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 05

    Feb

  • 12

    Feb

  • 12

    Feb

  • 14

    Mar

HTBX

Heat Biologics

$0.40

-0.0123 (-2.98%)

08:07
01/19/18
01/19
08:07
01/19/18
08:07
Syndicate
Breaking Syndicate news story on Heat Biologics »

Heat Biologics enters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEPT

Neptune Technologies

$2.91

-0.11 (-3.64%)

08:07
01/19/18
01/19
08:07
01/19/18
08:07
Hot Stocks
Neptune Technologies announces research agreement »

Neptune Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMLP

Golar LNG Partners

$22.41

-0.5 (-2.18%)

08:06
01/19/18
01/19
08:06
01/19/18
08:06
Hot Stocks
Golar LNG Partners secures new long-term FSRU contract »

Golar LNG Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.